Theravance Biopharma Inc logo

Theravance Biopharma Inc

TBPH | NASDAQ
Chart Builder DCF Calculator
$17.06
+$0.01 (+0.06%)
Sep 22, 2026, 10:47 AM ET · Market open
Fiscal Year
Period Ending
FY 2025
Dec 30, 2025
FY 2024
Dec 30, 2024
FY 2023
Dec 30, 2023
FY 2022
Dec 30, 2022
FY 2021
Dec 30, 2021
FY 2020
Dec 30, 2020
Cash & Equivalents
167.81M 37.8M 39.55M 298.17M 89.96M 81.47M
Short-Term Investments
147.55M 50.55M 62.88M 29.31M 83.51M 211.47M
Long-Term Investments
14.35M n/a n/a n/a 68.37M 833K
Other Long-Term Assets
22.5M 157.32M 203.1M 201.94M 3.23M 15.2M
Receivables
95.54M 68.44M 17.47M 16.79M 57.6M 69.67M
Inventory
n/a n/a n/a n/a n/a n/a
Other Current Assets
7.56M 4.2M 11.6M 7.68M 8.56M 10.36M
Total Current Assets
418.46M 161.07M 133.54M 353.46M 249.87M 393.34M
Property-Plant & Equipment
30.27M 35.77M 45.36M 52M 53.35M 59.68M
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
67.11M 193.09M 248.46M 253.94M 124.95M 75.72M
Total Assets
485.57M 354.16M 382M 607.4M 374.82M 469.06M
Account Payables
2.57M 2.24M 1.52M 1.55M 3.1M 6.78M
Deferred Revenue
n/a n/a n/a 24K 98K 11.52M
Short-Term Debt
10.95M n/a n/a n/a 17.44M 29.2M
Other Current Liabilities
6.91M n/a 12.88M -24K 25.15M 40.83M
Total Current Liabilities
38.3M 32.09M 24.77M 28.72M 58.59M 123.57M
Long-Term Debt
32.8M n/a n/a n/a 599.39M 599.84M
Other Long-Term Liabilities
313K 107.42M 99M 91.29M 2.18M 1.83M
Total Long-Term Liabilities
150.55M 146.53M 144.24M 136.89M 654.81M 649.24M
Total Liabilities
188.85M 178.62M 169M 165.6M 713.39M 772.81M
Total Debt
75.5M 49.82M 49.16M 52.16M 669.52M 676.26M
Book Value
296.72M 175.55M 213M 441.8M -338.57M -303.75M
Book Value Per Share
5.76 3.59 3.85 6 -4.87 -4.87
Common Stock
1K n/a n/a 1K 1K 1K
Retained Earnings
-859.63M -965.52M -909.1M -853.91M -1.73B -1.53B
Comprehensive Income
61K 7K -65K -15K n/a 47K
Shareholders Equity
296.72M 175.55M 213M 441.8M -338.57M -303.75M
Total Investments
161.9M 50.55M 62.88M 29.31M 151.88M 212.31M

© 2026 bestshares.com. All rights reserved.